Clinical Trial

A Phase I Clinical Trial to Evaluate the Effect of Itraconazole on the Pharmacokinetics of HS-10504

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This is a single-center, open-label, fixed-sequence, self-controlled Phase I clinical study with a planned enrollment of approximately 18 healthy participants.
Trial Details
NCT Number NCT07764692
Lead Sponsor Jiangsu Hansoh Pharmaceutical Co., Ltd.
Conditions Healthy Participants
Enrollment 8 participants
Start Date 2026-08-01
Primary Completion 2027-03-01 (estimated)
Study Completion 2027-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-08-14